IPI-504, a novel and soluble HSP-90 inhibitor, blocks the unfolded protein response in multiple myeloma cells

Author： Patterson Jon Palombella Vito Fritz Christian Normant Emmanuel

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.61, Iss.6, 2008-05, pp. : 923-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Implication of Unfolded Protein Response and Autophagy in the Treatment of BRAF Inhibitor Resistant Melanoma

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 3, 2016-02 ,pp. : 291-298

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 47-54

Spandidos Publications

Access to resources Recommend Favorite

Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

By Zhang Chongyu Xu Yunze Chen Dongning Zhao Juping Shen Zhoujun Wu Yuxuan Zhu Yu

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4065-4071

Springer Publishing Company

Access to resources Recommend Favorite

Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 907-926

Spandidos Publications

Access to resources Recommend Favorite

Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation

By Machida H. Matsumoto Y. Shirai M. Kubota N.

International Journal of Radiation Biology, Vol. 79, Iss. 12, 2003-12 ,pp. : 973-980

Informa Healthcare

Access to resources Recommend Favorite